THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 101 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $2,104,000 | +7.7% | 205,680 | -5.4% | 0.00% | 0.0% |
Q2 2022 | $1,953,000 | +5480.0% | 217,527 | +13470.0% | 0.00% | – |
Q1 2021 | $35,000 | -72.4% | 1,603 | -78.9% | 0.00% | – |
Q4 2020 | $127,000 | +202.4% | 7,583 | +171.2% | 0.00% | – |
Q3 2020 | $42,000 | -56.7% | 2,796 | -38.1% | 0.00% | – |
Q2 2020 | $97,000 | +410.5% | 4,514 | +436.1% | 0.00% | – |
Q1 2020 | $19,000 | -88.7% | 842 | -87.0% | 0.00% | – |
Q4 2019 | $168,000 | +73.2% | 6,496 | +30.7% | 0.00% | – |
Q3 2019 | $97,000 | -94.3% | 4,969 | -95.2% | 0.00% | -100.0% |
Q2 2019 | $1,696,000 | +21100.0% | 103,856 | +28276.0% | 0.00% | – |
Q1 2019 | $8,000 | -65.2% | 366 | -59.3% | 0.00% | – |
Q4 2018 | $23,000 | +21.1% | 899 | +53.7% | 0.00% | – |
Q3 2018 | $19,000 | +35.7% | 585 | -1.2% | 0.00% | – |
Q2 2018 | $14,000 | -90.7% | 592 | -90.5% | 0.00% | – |
Q1 2018 | $151,000 | +694.7% | 6,210 | +796.1% | 0.00% | – |
Q4 2017 | $19,000 | -5.0% | 693 | +18.5% | 0.00% | – |
Q3 2017 | $20,000 | -13.0% | 585 | 0.0% | 0.00% | – |
Q2 2017 | $23,000 | +4.5% | 585 | 0.0% | 0.00% | – |
Q1 2017 | $22,000 | +37.5% | 585 | 0.0% | 0.00% | – |
Q4 2016 | $16,000 | +60.0% | 585 | +120.8% | 0.00% | – |
Q3 2016 | $10,000 | +150.0% | 265 | +47.2% | 0.00% | – |
Q2 2016 | $4,000 | -33.3% | 180 | -42.5% | 0.00% | – |
Q1 2016 | $6,000 | +20.0% | 313 | 0.0% | 0.00% | – |
Q4 2015 | $5,000 | +400.0% | 313 | +135.3% | 0.00% | – |
Q3 2015 | $1,000 | -50.0% | 133 | 0.0% | 0.00% | – |
Q2 2015 | $2,000 | 0.0% | 133 | 0.0% | 0.00% | – |
Q1 2015 | $2,000 | 0.0% | 133 | 0.0% | 0.00% | – |
Q4 2014 | $2,000 | – | 133 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chescapmanager LLC | 1,134,718 | $23,160,000 | 2.47% |
Baupost Group | 8,735,168 | $178,285,000 | 1.42% |
Orbimed Advisors | 6,219,110 | $126,932,000 | 1.19% |
CM Management, LLC | 50,000 | $1,021,000 | 0.76% |
Tekla Capital Management LLC | 456,296 | $9,313,000 | 0.32% |
Rock Springs Capital Management LP | 682,600 | $13,932,000 | 0.30% |
Virtus ETF Advisers LLC | 32,871 | $671,000 | 0.28% |
Cormorant Asset Management, LP | 550,000 | $11,226,000 | 0.25% |
DAFNA Capital Management LLC | 41,165 | $840,000 | 0.20% |
PEREGRINE CAPITAL MANAGEMENT LLC | 484,206 | $9,883,000 | 0.18% |